Erythrocyte Protoporphyrin Fluorescence as a Biomarker for ...
Recommend Documents
Jul 30, 2012 - Open Access. Zinc erythrocyte protoporphyrin as marker of malaria risk in pregnancy - a retrospective cross-sectional and longitudinal study.
Aug 4, 2017 - Brian C. Wilson, PhD,5 Frederic Leblond, PhD,6,7 Mikael Marois, BE,4 and Keith D. ... croscope (Carl Zeiss Surgical GmbH) that was already.
Dec 22, 2004 - association with smoking and personal hygienic behaviour among lead exposed .... from wearing their personal protective equipment. Figure 1.
subacute bacterial endocarditis. 70 left flank mass. 287 congenital heart disease, anemia. 476 lead poisoning, alcoholic hepatitis. 101 iron deficiency, peritonitis.
The flash lamp was thyratron-triggered (Applied Photophysies Ltd. : model 435 /012), air-filled and run at 20 KHz with 4 KV applied across a 1.5 mm elec-.
chemicals was investigated by assessing their ability to stimulate vitellogenin synthesis in cultured hepato- cytes obtained from male rainbow trout. Nonylphenol.
Those CMML patients with SETBP1 mutations had higher baseline WBC counts. SETBP1 mutations were more commonly associated with ASXL1 mutations and.
Sep 4, 2016 - surgery are the most common treatment options. ..... MAL fluorescence volumes with post-Mohs surgical defect volumes [7]. The area of.
Mar 12, 2009 - KEY WORDS: Systemic lupus erythematosus, E-C4d, Complement, Autoimmune ... anti-C1q antibodies (all three for assessing disease activity).
F1 was, however, still a better template than chick erythrocyte chromatin depleted of both. F2C and F1. .... Template activity of chick-erythrocyte (e) and calf-.
Nov 28, 2012 - 7.6 software, and the median fluorescence intensities and standard ... were washed of free dye and imaged by confocal microscopy (top panel). BODIPY ..... (24) Ahn, S.; Jung, S. Y.; Seo, E.; Lee, S. J. Gold Nanoparticle-.
Erythrocyte Protoporphyrin Fluorescence as a Biomarker for ...
Erythrocyte Protoporphyrin Fluorescence as a Biomarker for Monitoring Antiangiogenic Cancer Therapy. Authors; Authors and affiliations. Flávia Gomes de ...
J Fluoresc (2010) 20:1225–1231 DOI 10.1007/s10895-010-0672-7
ORIGINAL PAPER
Erythrocyte Protoporphyrin Fluorescence as a Biomarker for Monitoring Antiangiogenic Cancer Therapy Flávia Gomes de Góes Rocha & Karen Cristina Barbosa Chaves & Cinthia Zanini Gomes & Camila Barricheli Campanharo & Lilia Coronato Courrol & Nestor Schor & Maria Helena Bellini
Received: 2 February 2010 / Accepted: 4 May 2010 / Published online: 18 May 2010 # Springer Science+Business Media, LLC 2010
Abstract Renal cell carcinoma (RCC) remains one of the greatest challenges of urological oncology and is the third leading cause of death in genitourinary cancers. RCCs are highly vascularized and are amenable to antiangiogenic therapy. Endostatin (ES) is a fragment of collagen XVIII that possesses antiangiogenic activity. In this study, we examined the potential of erythrocyte PpIX fluorescence spectroscopy for monitoring the efficacy of antiangiogenic therapy in metastatic renal cell carcinoma (mRCC), using an orthotopic metastatic mouse model. Balb/C-bearing Renca cells were treated with NIH/3T3-LendSN cells. Lung weight, nodule area, microvascular area (MVA), and erythrocyte PpIX fluorescence were evaluated. Emission spectra were obtained by exciting the samples at 405 nm. There was a significant decrease in lung wet weight, lung nodule area and MVA in the treated group compared to the control group (P
